Studies on Human Scar Tissue Proteoglycans  by Swann, David A. et al.
0022-202X/ 85/8406-0527$02.00/ 0 
'J'H E JOURNAL OF IN VESTI GATIVE DI>KMATOLOGY, 84:527- 531, 1985 
Copyr ight © 1985 by The Williams & Wilkins Co. 
Vol. 84, No.6 
Printed in U.S.A . 
Studies on Human Scar Tissue Proteoglycans 
DAVID A. SWANN, PH.D., HARIG. GARG, PH.D., WALTER JUNG, M .D. , AND HEATHER HERMANN, A.B. 
D epartments of Su.rgery, Biological Chemistry, and Pathology, Harvard Medical School at the Shriners Bu.rns Jn.stitu.te and Massachusetts 
General Hospital, Boston, Massachusetts, U.S.A. 
The proteoglycans (PGs) in pooled normal scars and 
pooled hypertrophic scars were extracted with 4 M 
guanidinium chloride and isolated by DEAE-cellulose 
chromatography. The PG samples were then fr action-
ated further by dissociative CsCl density gradient sedi-
mentation. Following cleavage of the density gradient 
pG fractions with alkaline NaB3 H4 , the glycosamino-
glycan (GAG) constituents were isolated and analyzed 
by quanti tative cellulose acetate electrophoresis. In ad-
dition, single samples of normal skin and a keloid scar 
were also a nalyzed. 
The results showed that the hypertrophic scars had a 
higher average content of extractable and also r esidual 
pGs than did the normal scars but a wide range of values 
was obtained for each type of scar. Some differences 
were noted in the amounts and distribution of the GAGs 
in CsCl g radient fractions, in the different types of scar 
tissue . The PGs in tissues were distributed in low-, 
medium-, a nd high density fractions and are, therefore, 
heterogeneous. Dermata n sulfate (DS) was the major 
GAG in e ach tissue and smaller quantities of chondroitin 
sulfate (CS), heparan sulfate (HS), and heparin (HP) 
were also present. In addition, 2 other GAG constituents 
were also detected. Based on the susceptibility of these 
GAGs to enzymes and nitrous acid treatments, one was 
a HS or HP while the second was a DS. The major 
differences in the PG composition of the scar tissues 
were the higher proportions of low-density CS-PGs in 
the keloid scar and of low density DS-PGs in hyper-
trophic and keloid scars. 
The dermis conta ins differen t types of glycosam inoglycans 
GAGs [ 1 ] that are associated with the collagen-rich extracel-
lular matrix. The GAGs present in t he greatest amounts a re 
hyaluronate (HA), which is distributed througho~t t he dermis 
extr acellula r matrix but with higher concentratiOns near the 
surface, a nd dermatan sulfate (DS) which is fairly evenly dis-
tributed th roughout the dermis [2,3 ]. In addition , smaller quan-
tities of c hondroitin sulfate (CS), heparin (HP), and heparan 
sulfate (HS) are a lso present (4,5]. Following injury, the healing 
process involves the formation of sea: t i ssu~, but little is known 
about the factors t hat regulate t he formatwn of scars a nd a re 
responsible for abnormal scarring. It is known, however, that 
the GAG conten t is increased in hypertrop htc scars compared 
to n ormal scars (6-8] and that there are a lso changes in the 
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types of collagen, the solubili ty and types of collagen links, and 
the organization of t he collagen bundles [9- 11] . 
The sulfated GAGs occur in tissues as polysaccharide side 
chains covalently linked to protein [12] . These proteoglycans 
(PGs) occur in a ll tissues of the body at cell surfaces [13], as 
components of basement membranes [14], and in varying 
amounts in t he extracellular matrix of tissues [15]. The close 
association of PGs with collagen (16] suggests that they may 
play a role in the organization of collagen fibers in normal 
tissues as well as the abnormal arrangement in scar t issues. 
The most widely studied PGs have been those extracted from 
cartilage with dissociative solvents [17]. A high proportion of 
cart il age PGs are high-molecular-weight, high-density constit-
uents that contain CS as t he major type of GAG side chain 
[18]. Smaller amounts of low-density, low-molecular-weight CS 
containing PGs, however, are also present [19] . Studies on skin 
PGs (20-25] have led to the isolation of the major DS-PG, and 
CS containing PGs were also extracted from skin (21]. 
The properties of t he PGs in scar t issues have not been 
reported, and thus it is not clear whether t he differences in the 
pattern of GAGs in normal and abnormal scars is due to 
qualitative and/or quantitative changes in t he types of PG 
constituents. The present study was carried out to obtain 
preliminary informat ion about t he types of PGs in scar t issues 
and to determine whether t here are major differences in t heir 
properties in diffe rent scar tissues. 
MATERIALS AND METHODS 
Human skin and scar samples were obtained following surgery and 
the type of scar was determined by routine histologic examination 
[26]. The criteria used for evaluating tissue as a normal scar were the 
presence of a thin atrophic epidermis and the presence of dermal 
collagen in fairly t ightly packed, thick bundles running parallel to the 
surface. Scar tissue with a raised nodular growth pattern and whorls of 
concent ric collagen bundles, cells, and blood vessels were classed as 
hypertrophic [27,28]. The keloid scar was characterized by its raised 
and overhanging border and a more exaggerated nodular growth pattern 
than the hypertrophic scars [29]. The normal skin was from the breast 
of a 53-year-old fema le patient. The keloid scar was excised from the 
arm of a 14-year-old fema le. Normal and hypertrophic scar specimens 
were from males and females ranging from 4- 23 years of age. After 
collection, skin and scar tissues were stored by freezing at -2o·c for 
periods of up to 3 months. A total of 42 hypertrophic scars and 32 
normal scars were used in this study. The average time that elapsed 
between injury and excision was 55 months for the hypertrophic scars 
(range, 5- 252 months). The ages of the normal scars were 2- 156 months 
with an average age of 71 months. The age of the keloid scar was 96 
months. The hypertrophic scar tissues were pooled into 11 batches and 
the normal scars into 8 batches, to be processed by extraction, isolation, 
and fractionation of the PGs. 
Extraction of Tissu.es a.nd Fractionation Procedures 
Scar and skin tissues were dissected free from fat, diced into 3-mm 
pieces, extracted repeatedly with acetone, and air dried. The dried 
tissue was then ground in a Wiley mill and the recovered dry weight of 
ground tissue determined. The ground tissue was then extracted (X 2) 
with 4 M guanidinium chloride (GdmCl) (10 ml solvent per g dry tissue 
for 48 h) containing 0.05 M sodium acetate, pH 5.8, and proteinase 
inhibitors (1 mM phenylmethanesulfonyl fluoride, 1 mM p-chloro-
mercuribenzoic ac id, and 10 mM disodium EDTA). After centrifugation 
(90,000 gat r.,. 30 min in a Beckman 60 T i rotor) the extract superna-
tants were combined and dialyzed successively against disti lled water, 
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1 M NaCI, distilled water (until free of Cl ions), and fina lly against 6 
M urea in 50 mM sodium acetate, pH 5.8 (Buffer A). The dialyzed 
extracts were applied directly to a DEAE-cellulose column (26 x 5 em) 
packed with Whatman DE-52 and equilibrated with Buffer A. The 
colu mn was eluted in sequence with (1) 450 ml of Buffer A, (2) a linear 
gradient of 0- 0.2 M NaCl in Buffer A (total volumn 900 ml) , and (3) a 
linear gradient of 0.2-2 M NaCI in Buffer A (total volume, 900 ml). 
The recovered B fractions obtained by DEAE-cellulose chromatog-
raphy obtained fro m 5 batches of normal scars (average scar age 60 
months) were pooled and then fractionated further by density gradient 
sedimentation (CsCl, initial density 1.50 g/ml in 4 M GdmCl, 0.05 M 
sodium acetate pH 5.8, 90,000 g at 4 ' C for 48 h in a Beckman 60 Ti 
rotor). T he high-, medium-, and low-density fractions were dialyzed 
against distilled water, 1 M NaCl, disti lled water unt il chloride-free, 
and then freeze-dried. A similar fractionation was performed on the 
pooled B fractions from 4 batches of hypertrophic scars (average scar 
age 70 months) and the B fraction obtained from the single keloid scar. 
Allwline-Borohydride Treatment 
T he scar tissue density gradient and the normal sk in DEAE B 
fractions were treated with 50 mM NaOH/1 M NaB H. (0.35 ml per mg 
sample) containing NaB"H4 (25 J.LCi/ ml) at 37' C for 24 h [30]. After 
neut ra lization with acetic ac id the samples were dialyzed against dis-
t illed water, freeze-dried, and fractionated by DEAE-cellulose chro-
matography. The alkaline borohydride-treated samples were dissolved 
in Buffer A and applied to a 2.0 x 1.0 em column pac ked with Whatman 
DE-52 and equilibrated with Buffer A. The column was then eluted 
with 6 X 1 ml Buffer A, 6 X 1 ml Buffer A co ntaining 0.2 M NaCI, and 
6 x 1 ml Buffer A containing 2M NaCl. The quantities of radioactivi ty 
in fractions a n<;! samples were determined using a liquid scintillation 
counter. 
Analytical Procedures 
The protein contents of column fract ions were measured by absorb-
ance at 280 nm. T he uronic acid content of samples was determined 
using a carbazole reaction [31). Glucosamine and galactosamine anal-
yses of hydrolyzed samples were performed using an animo acid ana-
lyzer [32]. 
Analysis of GAG Fractions 
T he GAG chains obtained by alkaline borohydride treatment of PG 
fractions were analyzed by electrophoresis on cellulose acetate as 
descr ibed by Cappelletti eta! [33). HP was obtained from Sigma (No. H-
::1 125) and other reference GAG samples were kindly supplied by Dr. 
M. B. Mathews and Dr. A. J. Cifonelli (University of Chicago). Cellu lose 
acetate electrophoresis analyses were performed on samples before and 
after treatme nt with chondroitinase ABC, AC-Il enzymes [34 ) (ob-
ta ined fro m Miles Laboratories), and streptomyces hyaluronidase [35] 
(obtained from Calbiochem) . T hese digestion s were performed at 3TC 
for 16 h using 0. 1 unit of enzyme/20 Jlg GAG sample in disti lled water 
after the pH had been adjusted to the recommended values. The 
quantities of individual GAG constitutents detected following electro-
phoresis were determined using the method described by Newton et a! 
[36]. The GAG alcian blue band was cut from the cellulose acetate 
plate and the quant ities of extracted complex determined by measuring 
the absorbance at 678 nm. The sample absorbance values were com-
pared with those of reference GAGs that had been treated by the same 
procedures. Calibration curves were obtained with 1- 4 J.Lg of each 
sta ndard GAG. 
RESULTS 
A total o f 8 batches of pooled normal scars and 11 batches 
of pooled hype rtrophic sca rs, in addition to the single samples 
of keloid sca r a nd normal s kin , were analyzed in this study. 
Following fractionat ion of t he co nstitutents extracted from a 
hype rt rophic scar with 4 M GdmCl by chromatography on 
DEAE-cellulose, a se ries of protein fractions were eluted at low 
ionic stren gths (Fig 1) . As t he NaCl concentration was in -
creased , 2 uronic acid -conta ining fracti ons were eluted from 
t he co lumn as indicated in Fig 1. Fraction A was eluted at an 
ionic strength of 0.19 and Fraction B at 0.50. The column 
fractions containing the protein peaks and t he 2 uronic acid 
fractions (Fig 1, A a nd B) were pooled, d ia lyzed against distilled 
water, a nd freeze -dried. Infra red analysis (results not shown) 
of t he A a nd B fractions s howed that the A fraction had an 
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FIG 1. DEAE-cellulose chromatography of constituents extracted 
from hypertrophic scar wi th 4 M GdmCl. The column fractions were 
analyzed to determine the absorbance at 280 nm (0 ) , the uronic ac id 
content (6}, and the conduct ivity (e). The column fractions indicated 
were pooled to yield Fractions A and B. 
TABLE I. Yield of protein, and hexosamines in the hyaluronate, 
proteoglycan, and tissue residue fractions from normal a.nd 
hypertrophic scars 
Fractions T issue 
Tissue Protein Hya luronate Prot.eoglycan res idue 
(mg) (Mg) (Mg) (Mg) 
Normal sca r 72 ± 19 206 ±59 445 ± 144 365 ± 129 
Hypertrophic 99 ± 36 249 ± 49 679 ± 256 687 ± 351 
scar 
The values shown are the averages ± SD obtained with 8 batches of 
pooled normal scars and 11 batches of pooled hype rt rophic scars. The 
proteins, hyaluronate, and proteoglycan fractions were obtained by 
DEAE-cellulose chromatography (Fig 1). The values are all expressed 
per gram of t issue dry weight . 
a bsorpt ion spectrum simila r to HA, whereas the B fraction ha d 
a peak absorptio n at 1240 em- • indicating t he presence of 
sulfated constituents [37] . Similar profi les of constituents we re 
obtained when normal s kin , norma l scar, and keloid scar ex-
t racts were fractionated by DEAE-cellulose chromatography. 
The y ields of t he total quantities of material in t he protein 
peaks and t he quantities of hexosamine in the HA (A), PG (B), 
a nd tissue residue fractions are s hown in Table I. 
The pooled DEAE PG (B) frac t ions (Fig 1) obtained from 5 
of the no rmal sca r batches , 4 of the hypertrophic scar batches, 
and t he single keloid scar were then fractionated by CsCl 
dens ity gradient sedimentation . The pro files of uronic acid-
containing co nstituents obtained are s hown in Fig 2. The 
density gradient fractions were pooled as indicated to give 
high-, medium-, and low-de ns ity fractions, la beled A, B, and C, 
respectively. 
The A, B, and C dens ity gradient fractions obtained from 
t he scar t issues and the normal skin DEAE B fraction were 
then treated with alkaline bo rohydride, and the sulfated GAG 
constituents isolated by DEAE chromatography (Fig 3) were 
analyzed by cellu lose acetate electrophoresis as described in 
MateriaL> and Methods. The type of electrophoretic pattern 
obtained with the normal scar high -density A fraction is shown 
in Fig 4. A mixture of standard GAGs gave the profile shown 
in column A. The referen ce heparin gave the expected band 
indicated by HP as well as a second band (HP'). The normal 
scar , high-den sity sample (Fig 4, column B) showed a band (I) 
with the same mobility as HP, a band (II) with a slightly greate r 
mobility t han HP', a ba nd with the same mobility as DS, a 
fa int diffuse amoun t of materia l (IV) in t he HS region , a band 
(V) wit h a s lightly greater mobility than HA, and a band (VI) 
with a s imilar mobili ty to chondroitin 6 su lfate. After treatment 
with streptomyces hyaluronidase (results not shown), there was 
no detectable change in the profile of these a lcian blue-staining 
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FIG 2. Fract ionation of scar p roteoglycan fractiOns (F1g 1) by dis-
soc iative CsCl dens ity gradient sedimentation. T he d istribu tion of 
consti tuents obta ined from norma l scar is shown in (/ ): from hyper-
t rophic (If) , and from keloid scar in C.IJI). T he ~rad1en t tractwns were 
a n a lyzed to dete rmine t he content of uron1c ~c1d (6) and the dens1ty 
(e). T h e gradient fractions were pooled as 111d1cated to y1eld high-
de n sity (A), medium -density (B), and low-dens1ty (C) fractzons. 
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F IG 3. Isolat ion of labeled GAGs by DEAE-cellulose chromatogra-
p h y. Following alkaline NaB 3H 4 t reatment of P G samples, t he lab: led 
G A Gs were isolated by DEAE-cellulose chromatography as descnbed 
in t h e text. The arrows (I) and (3) indicate the beginning elu t ion 
positio n s of t he Buffer A/ 0 .2 M NaCl and Buffer A/2 M NaCl solvents, 
resp ecti vely, and arrows (2) and (4) indicate the elut ion positio ns of 
refer e n ce HA and CS, respectively. T he fractions indicated were pooled 
and analyzed by quant itative cellulose acetate electrophoresis. 
con stit uen ts. Following t reatment wi t h chondroitinase AC en-
zym e , b and VI was not detected, and ba nds V, IV, III, II , and I 
remained (Fig 4, co lumn C). Chondroitinase ABC t reatment 
(results not shown) removed bands VI, V, and III . Bands 1, II , 
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FIG 4. Cellulose acetate electrophoresis of GAGs. A mixtu re of 
reference GAGs (HP, HP', DS, HS, HA, and CS) were appl ied in 
colum n A. The GAGs from a normal scar high-density fraction are 
shown in column B. T he bands observed in t his and other sk in and 
scar GAG fractions a re indicated by the lines marked I , 11, 111, I V, V, 
and VI. Column C shows the GAG bands obtained after t reatment of 
t he normal scar high-density fract ion wit h chondroit inase AC enzyme. 
TABL E II. Detection of glycosaminoglycan bands (Fig 4) 
Glycosaminoglyca n band" 
Treatment 
II Ill IV v VI 
Streptomyces hyaluronidase + + + + + + 
Chondroit inase AC + + + + + 
Chondroit inase ABC + + + 
N itrous acid + + + 
• (+) Indicates detection of band simi la r to that of t he untreated 
sa mple; (-) indicates not detected. 
and IV were not detected after treatment with ni trous acid. 
These resu lts, summarized in Table II, indicate that band I is 
HP, and band II is a HP or HS-like GAG [33], band III is DS, 
band IV is HS, band V is a DS-like GAG, and band VI is a CS. 
T he quant it ies of these different GAG constituents in the scar 
density gradient fractions were calculated by measuring the 
absorbancies obtained with each samp le band using t he ca li-
bration curve obtained with the corresponding refe rence GAGs. 
The percentage of the total sul fated GAGs in each of the dens ity 
gradient fractions was t hen calculated. T he resul ts obtained fo r 
the pooled normal scar and hypert rophic scar samples, the 
single keloid sca r sample, and the normal skin, hya luronidase-
t reated DEAE B fraction, are shown in Table III. 
DISCUSSION 
The present study was carried out to obta in information 
about t he amounts and types of PGs in scar t issues. T he 
ext raction procedure employed yielded similar quant it ies of 
GAG constituents to those reported in an earlier study [7] but 
less t han t he quant it ies recovered from scar t issue fo llowing 
proteolytic digestion [8]. Hexosamine analysis of the HA, PG, 
and t issue residue fractions indicated t hat an average of 36% 
and 43 % of the normal scar and hypertrophic scar GAGs, 
respectively, were not ext racted by t he 4 M GdmCI treatment 
(T able I) . 
ln addi tion to the sul fated GAG constituents, (H P, DS, HS, 
and CS) known to be present in kin and sca r tissues [6- 8] we 
observed the presence of 2 addi t ional bands (l abeled II and V, 
Fig 4). Reanalysis of samples afte r enzyme and ni t rous acid 
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TABLE Ill. Relative quantities of sulfated glycosaminoglyca.ns (GAGs) in cesium chloride density gradient fractions, expressed a.s a percentage of 
total GAGs 
Glycosaminoglycans• 
Band HP DS HS cs 
(I ) (II) (I II ) (IV) (V) (V I) 
Normal scars 
High-density 4.84 5.40 24.49 7.46 6.73 7.35 
Medium-density 1.83 2.29 7.78 3.78 3.67 4.05 
Low-density 1.79 1.79 6.34 2.73 3.89 3.76 
Total 8.46 9.48 38.61 13.97 14.29 15.16 
Hypert rophic scars 
High-density 4.36 2.53 20.01 8.74 5.61 7.05 
Medium-density 1.39 0.69 14.89 4.50 3.22 7.21 
Low-de nsity 1.58 0.85 9.99 2.85 1.88 2.66 
Total 7.33 4.07 44.89 16.09 10.71 16.92 
Keloid scars 
High-density 2.17 3.26 11.83 4.66 7.38 11.68 
Medium-density 1.19 1.46 9.52 2.40 3.78 8.45 
Low-density 2.19 1.81 11.72 5.54 4.05 6.90 
Total 5.55 6.53 33.07 12.60 15.21 27.03 
Normal skin 8.02 10.9 33.2 13.7 22.1 12.1 
" The ident ity of GAGs was determined by their mobilities when analyzed by cellulose acetate electrophoresis (band no. is given in parentheses) 
and their susceptibility to enzyme and ni t rous acid treatments (Table II , Fig 4). 
treatmen ts indicate t hat band II is a HP or HS-like GAG and 
band V is a DS. Ot her studies [33) noted the occurrence of an 
H S wit h a s imila r mobili ty to band II. Additional evidence for 
t he identity of band V as a DS component that a lso distin -
gu ishes it from HA is that fibroblasts from skin and scar tissues 
in cell culture syn t hesize a ~'·so. conta ining constitutent with 
t he same mobility as band V when fractions were analyzed by 
cellulose acetate electrophoresis [38]. Analys is of purified frac-
tions containing band V as the major GAG component have 
s hown t hat it has a high content of iduronic acid (D. A. Swann 
a nd H. G. Ga rg, unpublished data). These data support the 
conclusion t hat the ba nd V component is a type of DS. 
The hypertrophic scars had a higher average content of HA 
and PG co nstituents than did the normal scars, but a wide 
ran ge of va lues was obtained for both types of tissue (Table I). 
Simila r proportions of PG constituents were extracted from 
t he no rm al and hypertrophic scar tissues by the 4 M GdmCl 
t reatment. Uro nic acid analysis of t he keloid scar h yaluronate 
(A) a nd PG (B) fractions gave values of 510 llg a nd 1290 llg per 
g of t issue dry wt, respectively, which are higher than the 
ranges of t hese constituents obtained for the normal and hy-
pertrophic scars. When the pooled normal scar and hyper-
troph ic PG fract ions were fractionated by CsCl density gradient 
sedimentation and t he low-, medium -, and high-density frac -
t ions were analyzed for GAG constituents, the GAGs were 
distributed t hroughout t he gradient fractions (Table III). This 
indicates t hat the PGs are hete rogeneous. Studies on bovine 
skin PGs [21 ,22] showed t hat the CS-PGs sedimented primarily 
at hi gh densities wh ile t he DS-PGs sedimented m ainly at low 
densities a nd t hat a partial sep a ration of these P Gs could be 
obta ined by density gradient sedimentation. Our results, how-
ever, s how a similar distribution of CS and DS PGs in the scar 
t issue fractions . The major diffe rences between pooled normal 
sca r and pooled hypertrophic scar GAGs are the lower propor-
tion of t he band II and band V GAGs and the higher content 
of DS (band III ) in hypertrophic scar tissue. There were a lso 
so me differences in t he distribution of these constituents in t he 
density gradient fractions. GAG analys is of the keloid scar PG 
density gradi en t fractions showed severa l differences from the 
pooled norma l and hypertrophic scar samples , in pa rticular, the 
lower proportion and a ltered di stribut ion of DS a nd the higher 
proportion of CS. 
An unexpected finding in t hese experimen ts was the consist-
ent occurrence of a GAG band (V, Fig 4) with a sli ghtly higher 
mob ili ty than HA. This presumpt ive DS compone nt was pre-
sent in a ll of t he tissue and it a lso occurred in the normal skin 
(Table III ). 
Further interpretation of the data is limited because the 
normal and hypertrophic scar tissues were pooled samples and 
only a s ingle sample of keloid scar and normal skin were 
analyzed . The data, however, show that scar PGs occur as 
components with a broad range of buoyant densities and are 
therefore, very heterogeneous. The primary factor influencin~ 
the buoyant density of PGs is the ratio of carbohydrate to 
peptide constituents. This ratio can be influenced by changes 
in t he length of the protein core and by the number length 
and composition of the GAG and oligosaccharide sid~ chains: 
Further experiments are now in progress to determine the 
structura l basis for the heterogeneities observed in the different 
types of scar PGs. 
The authors would like to thank S. Sotman and C. Hendry for 
technical assistance. 
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